Advanced and IP-Protected LC-HRMS Data Processing Technology

We integrate a proprietary, advanced Background Subtraction Filter tool with commercial MetID software platforms, enabling untargeted data processing to detect and identify both common and uncommon metabolites across a wide range of drug modalities.

Licensed Radiolabeled ADME Laboratory

We are the only private company in Suzhou that is fully licensed and equipped to conduct both ¹⁴C- and ³H-radiolabeled ADME studies in animals and humans, offering comprehensive support for drug metabolism and pharmacokinetic research across preclinical and clinical stages.

Customized Approach

We design and execute biotransformation studies carefully tailored to the unique scientific goals, timelines, and regulatory requirements of each client’s project. Our approach ensures studies fit the drug’s characteristics and development stage, providing insights aligned with strategic objectives. We collaborate closely with clients to stay flexible, adapt to evolving needs, and deliver reliable data supporting regulatory submissions and decision-making.

Collaborative Capabilities

As a specialty CRO in biotransformation, we actively collaborate with DMPK, toxicology, bioanalytical, pharmacology, and clinical CRO partners to support a wide range of metabolite profiling and identification projects, ensuring integrated and comprehensive solutions across discovery and development stages.